{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:02:10Z","timestamp":1792735330683,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00238","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T10:52:27Z","timestamp":1571827947000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":116,"title":["Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment"],"prefix":"10.3389","volume":"6","author":[{"given":"George E.","family":"Fragoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nikiphorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Korsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert Rev Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.53.7.434","article-title":"Methotrexate-related pulmonary complications in rheumatoid arthritis","volume":"53","author":"Barrera","year":"1994","journal-title":"Ann Rheum Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","article-title":"Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion","volume":"73","author":"Pavy","year":"2006","journal-title":"Joint Bone Spine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13256-017-1333-0","article-title":"Methotrexate-induced Hypersensitivity Pneumonitis appearing after 30 years of use: a case report","volume":"11","author":"Salehi","year":"2017","journal-title":"J Med Case Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"bcr2014206123","DOI":"10.1136\/bcr-2014-206123","article-title":"Late-onset methotrexate-induced pneumonitis with neutrophilia in bronchoalveolar lavage fluid","volume":"2014","author":"Yamakawa","year":"2014","journal-title":"BMJ Case Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/ard.2005.045211","article-title":"Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease","volume":"65","author":"Inokuma","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1440-1843.2003.00420.x","article-title":"The role of interleukin-8 in interstitial pneumonia","volume":"8","author":"Fujimori","year":"2003","journal-title":"Respirology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/14397595.2014.898559","article-title":"Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis","volume":"26","author":"Yamakawa","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s10067-006-0480-2","article-title":"Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis","volume":"26","author":"Kameda","year":"2007","journal-title":"Clin Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst."},{"key":"B19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/2193-1801-3-751","article-title":"Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis","volume":"3","author":"Barakat","year":"2014","journal-title":"Springerplus."},{"key":"B20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/03009740600902403","article-title":"Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis","volume":"36","author":"Shimada","year":"2007","journal-title":"Scand J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med."},{"key":"B22","first-page":"2299","article-title":"Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis","volume":"24","author":"Ohosone","year":"1997","journal-title":"J Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s10165-010-0280-z","article-title":"Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA","volume":"20","author":"Shidara","year":"2010","journal-title":"Mod Rheumatol."},{"key":"B24","first-page":"51","article-title":"Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate","volume":"21","author":"Carroll","year":"1994","journal-title":"J Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/annrheumdis-2012-201944","article-title":"HLA-A*31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker?","volume":"72","author":"Furukawa","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1136\/annrheumdis-2017-211512","article-title":"HLA-A 31:01 is not associated with the development of methotrexate pneumonitis in the UK population: results from a genome-wide association study","volume":"76","author":"Bluett","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/RHU.0b013e3182314e34","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: increased prevalence with increasing latitude: an epidemiological study of trends in new zealand","volume":"17","author":"Jordan","year":"2011","journal-title":"J Clin Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/rheumatology\/35.5.446","article-title":"Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study","volume":"35","author":"Beyeler","year":"1996","journal-title":"Br J Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00296-002-0227-6","article-title":"Effect of methotrexate on pulmonary function in patients with rheumatoid arthritis\u2013a prospective study","volume":"22","author":"Khadadah","year":"2002","journal-title":"Rheumatol Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1378\/chest.109.4.933","article-title":"Pulmonary function in patients receiving long-term low-dose methotrexate","volume":"109","author":"Cottin","year":"1996","journal-title":"Chest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0022-3476(05)80923-0","article-title":"Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis","volume":"120","author":"Graham","year":"1992","journal-title":"J Pediatric."},{"key":"B32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/anr.1780320604","article-title":"Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis","volume":"32","author":"Wallace","year":"1989","journal-title":"Arthritis Rheum."},{"key":"B33","first-page":"302","article-title":"Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study","volume":"30","author":"Leiskau","year":"2012","journal-title":"Clin Exp Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s003930200025","article-title":"Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy","volume":"61","author":"Schmeling","year":"2002","journal-title":"Z Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s002960050047","article-title":"Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis","volume":"18","author":"Camiciottoli","year":"1998","journal-title":"Rheumatol Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thx.52.4.377","article-title":"Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis","volume":"52","author":"Schnabel","year":"1997","journal-title":"Thorax."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1378\/chest.104.5.1620","article-title":"Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis","volume":"104","author":"Leduc","year":"1993","journal-title":"Chest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/1753465816668780","article-title":"Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review","volume":"11","author":"Picchianti Diamanti","year":"2017","journal-title":"Ther Adv Respir Dis."},{"key":"B39","first-page":"944","article-title":"Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs","volume":"20","author":"Scherak","year":"1993","journal-title":"J Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1871528112666131230013059","article-title":"Methotrexate-induced pneumonitis: heterogeneity of bronchoalveolar lavage and differences between cancer and rheumatoid arthritis","volume":"13","author":"D'Elia","year":"2014","journal-title":"Inflamm Allergy Drug Targets."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/rheumatology\/ken356","article-title":"Variation of immunological response in methotrexate-induced pneumonitis","volume":"47","author":"Chikura","year":"2008","journal-title":"Rheumatology."},{"key":"B42","first-page":"101","article-title":"Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis","volume":"25","author":"Taniguchi","year":"2005","journal-title":"Int J Clin Pharmacol Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2169\/internalmedicine.41.467","article-title":"Detection and monitoring of methotrexate-associated lung injury using serum markers KL-6 and SP-D in rheumatoid arthritis","volume":"41","author":"Miyata","year":"2002","journal-title":"Intern Med."},{"key":"B44","first-page":"36","article-title":"The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients","volume":"25","author":"Romagnoli","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1148\/radiographics.20.5.g00se081245","article-title":"Pulmonary drug toxicity: radiologic and pathologic manifestations","volume":"20","author":"Rossi","year":"2000","journal-title":"Radiographics."},{"key":"B46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005382-200310000-00004","article-title":"Methotrexate-induced pulmonary injury: serial CT findings","volume":"18","author":"Arakawa","year":"2003","journal-title":"J Thorac Imaging."},{"key":"B47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J."},{"key":"B48","first-page":"355","article-title":"Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy","volume":"17","author":"Suwa","year":"1999","journal-title":"Clin Exp Rheumatol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1529-0131(199807)41:7<1327::AID-ART30>3.0.CO;2-T","article-title":"Experience with methotrexate-associated pneumonitis in northeastern England: comment on the article by Kremer et al","volume":"41","author":"Bartram","year":"1998","journal-title":"Arthritis Rheum."},{"key":"B50","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/ard.51.2.272","article-title":"Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis","volume":"51","author":"Cook","year":"1992","journal-title":"Ann Rheum Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment?","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax."},{"key":"B56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/rg.321105058","article-title":"Thoracic manifestations of collagen vascular diseases","volume":"32","author":"Capobianco","year":"2012","journal-title":"Radiographics."},{"key":"B57","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors","volume":"14","author":"Searles","year":"1987","journal-title":"J Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1513\/pats.200703-045MS","article-title":"Rheumatoid lung disease","volume":"4","author":"Brown","year":"2007","journal-title":"Proc Am Thorac Soc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1164\/ajrccm\/136.4.811","article-title":"Lower respiratory tract abnormalities in rheumatoid interstitial lung disease","volume":"136","author":"Garcia","year":"1987","journal-title":"Am Rev Respir Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Rojas-Serrano","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically-apparent RA-associated interstitial lung disease: A prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3899\/jrheum.150674","article-title":"Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials","volume":"43","author":"Conway","year":"2016","journal-title":"J Rheumatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/DDDT.S204730","article-title":"Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","article-title":"Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients","volume":"48","author":"Fern\u00e1ndez-D\u00edaz","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B65","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00296-016-3478-3","article-title":"Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study","volume":"36","author":"Akiyama","year":"2016","journal-title":"Rheumatol Int."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatology."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14306","article-title":"Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis","author":"Fui","year":"2019","journal-title":"Intern Med J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.23736\/S0031-0808.16.03260-2","article-title":"Methotrexate and lung disease in rheumatoid arthritis","volume":"59","author":"Conway","year":"2017","journal-title":"Panminerva Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.243.17.1715","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"243","author":"Cervantes-Perez","year":"1980","journal-title":"JAMA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","article-title":"Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis","volume":"13","author":"Catrina","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/rheumatology\/kex299","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","article-title":"Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes","volume":"16","author":"Nurmi","year":"2016","journal-title":"BMC Pulm Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clim.2014.08.004","article-title":"Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses","volume":"155","author":"Harlow","year":"2014","journal-title":"Clin Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N Engl J Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/rheumatology\/40.9.1022","article-title":"Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis","volume":"40","author":"Rajasekaran","year":"2001","journal-title":"Rheumatology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/bmj.2.4583.816","article-title":"Rheumatoid disease with joint and pulmonary manifestations","volume":"2","author":"Ellman","year":"1948","journal-title":"Br Med J."},{"key":"B79","first-page":"117","article-title":"Changes of the lung in rheumatoid arthritis\u2013rheumatoid pneumonia. A clinicopathological study","volume":"39","author":"B\u00e9ly","year":"1991","journal-title":"Acta Morphol Hung."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/annrheumdis-2013-203380","article-title":"Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study","volume":"73","author":"Chung","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B82","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0091-6749(84)90236-7","article-title":"Activated lung lymphocytes in hypersensitivity pneumonitis","volume":"74","author":"Mornex","year":"1984","journal-title":"J Allergy Clin Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/art.20765","article-title":"Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis","volume":"52","author":"Turesson","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B87","first-page":"118","article-title":"Rheumatoid arthritis: now and then","volume":"55","author":"Donaghy","year":"2016","journal-title":"Rheumatology."},{"key":"B88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.reumae.2011.12.001","article-title":"Interstitial lung disease related to rheumatoid arthritis: evolution after treatment","volume":"8","author":"Rojas-Serrano","year":"2012","journal-title":"Reumatol Clin."},{"key":"B89","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/14397595.2018.1481566","article-title":"Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept","volume":"29","author":"Mochizuki","year":"2019","journal-title":"Mod Rheumatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment","author":"Duarte","year":"2019","journal-title":"Rheumatology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e000473","DOI":"10.1136\/rmdopen-2017-000473","article-title":"Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic","volume":"3","author":"Druce","year":"2017","journal-title":"RMD Open."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"L998","DOI":"10.1152\/ajplung.00304.2017","article-title":"Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease","volume":"314","author":"Redente","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"105700","DOI":"10.1016\/j.intimp.2019.105700","article-title":"Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)","volume":"74","author":"Wu","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B97","first-page":"S35","article-title":"Mortality in rheumatoid arthritis: 2008 update","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin Exp Rheumatol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.005","article-title":"Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis","author":"Singh","year":"2019","journal-title":"Semin Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T11:05:23Z","timestamp":1571915123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":98,"alternative-id":["10.3389\/fmed.2019.00238"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00238","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"article-number":"238"}}